Difference between revisions of "Jürg Witmer"
m (Text replacement - "|twitter= " to "") |
m (Text replacement - "also served on " to "was also on ") |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
|wikipedia= | |wikipedia= | ||
|amazon= | |amazon= | ||
| − | |image= | + | |image=Jürg Witmer.jpg |
| − | |nationality= | + | |alma_mater=University of Zurich, University of Geneva |
| + | |nationality=Swiss? | ||
|birth_date= | |birth_date= | ||
|birth_place= | |birth_place= | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
| − | |constitutes=businessman | + | |constitutes=businessman, lawyer |
| + | |description=Big pharma single Bilderberg businessman | ||
}} | }} | ||
'''Dr. Jürg Witmer''' is a [[businessman]]. | '''Dr. Jürg Witmer''' is a [[businessman]]. | ||
| + | |||
| + | ==Background== | ||
| + | He holds a Doctorate in Law from the [[University of Zurich]], as well as a Degree in International Studies from the Graduate Institute of the [[University of Geneva]]. | ||
==Career== | ==Career== | ||
| − | Chairman at Interpharma Investments Ltd. He is on the Board of Directors at The Zuellig Group, Inc., Syngenta AG, Gold Coin Group and A. Menarini-Industrie Farmaceutiche Riunite–Srl. Dr. Witmer was previously employed as Chairman by Clariant AG, Non-Executive Chairman by Givaudan SA, General Manager by Roche Austria GmbH, General Manager & Regional Manager-Marketing by Roche Far East, Chief Executive Officer by Roche Group, and Head-Corporate Communications & Public Affairs by Roche Holding AG. He also | + | In 1978, Jürg Witmer joined [[Hoffmann-La-Roche]] in [[Basel]]. |
| + | |||
| + | Chairman at Interpharma Investments Ltd. He is on the Board of Directors at The Zuellig Group, Inc., Syngenta AG, Gold Coin Group and A. Menarini-Industrie Farmaceutiche Riunite–Srl. Dr. Witmer was previously employed as Chairman by Clariant AG, Non-Executive Chairman by Givaudan SA, General Manager by Roche Austria GmbH, General Manager & Regional Manager-Marketing by Roche Far East, Chief Executive Officer by Roche Group, and Head-Corporate Communications & Public Affairs by Roche Holding AG. He was also on the board at Bank Sal. Oppenheim jr. & Cie. (Switzerland) Ltd. (Broker). | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
Latest revision as of 15:56, 24 January 2023
 Jürg Witmer  (businessman, lawyer) | |
|---|---|
 | |
| Nationality | Swiss? |
| Alma mater | University of Zurich, University of Geneva |
Big pharma single Bilderberg businessman | |
Dr. Jürg Witmer is a businessman.
Background
He holds a Doctorate in Law from the University of Zurich, as well as a Degree in International Studies from the Graduate Institute of the University of Geneva.
Career
In 1978, Jürg Witmer joined Hoffmann-La-Roche in Basel.
Chairman at Interpharma Investments Ltd. He is on the Board of Directors at The Zuellig Group, Inc., Syngenta AG, Gold Coin Group and A. Menarini-Industrie Farmaceutiche Riunite–Srl. Dr. Witmer was previously employed as Chairman by Clariant AG, Non-Executive Chairman by Givaudan SA, General Manager by Roche Austria GmbH, General Manager & Regional Manager-Marketing by Roche Far East, Chief Executive Officer by Roche Group, and Head-Corporate Communications & Public Affairs by Roche Holding AG. He was also on the board at Bank Sal. Oppenheim jr. & Cie. (Switzerland) Ltd. (Broker).
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Bilderberg/2011 | 9 June 2011 | 12 June 2011 | Switzerland Hotel Suvretta St. Moritz | 59th meeting, in Switzerland, 129 guests |
